Hims, Inc. has an A+ rating from the BBB as of February 2025. Most negative reviews are about products related to sexual health rather than hair loss. Many reviewers complain that they were still ...

Continue reading for our full review of Hims, with all of the nuances of their hair loss and prevention products examined along with a full evaluation and comparison to alternatives in the UK.

was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

While Hims offers more options for sexual health and hair loss, Roman offers more options ... Read on for our full review and how to decide which one may work best for you. Our Medical Standards ...

"Hims," which advertises itself as an app for "hair loss, sexual health" and "Hers" which promotes "hair care, mental health." Morgan Stanley's research suggests the majority of downloads in ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Read our in-depth review of Hers. Minoxidil is a clinically proven and FDA-approved treatment for hair loss, leading to thicker ... the product once per day. Hims states that this shampoo is ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...

Hims launched in 2017, selling generic hair loss, sexual health, and skincare drugs online via telemedicine. It began selling weight loss copies in 2023.

Hims & Hers Health (NYSE: HIMS) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach delivered some good news for the mail-order drugs stock. Citing third-party ...